摘要
目的 探讨百里醌对体内外膀胱癌生长的影响及其机制.方法 百里醌作用人膀胱癌细胞株BIU-87后,四甲基偶氮唑盐(MTT)法检测细胞增殖;流式细胞术检测细胞凋亡;细胞免疫荧光检测核因子(NF)-κB转位变化;Western印迹检测膀胱癌细胞中NF-κB、生存素(survivin)和X连锁凋亡抑制蛋白( XIAP)蛋白表达;建立裸鼠膀胱癌皮下移植瘤模型,观察百里醌对裸鼠膀胱癌皮下移植瘤生长的影响;免疫组织化学法检测肿瘤组织中增殖细胞核抗原Ki-67、NF-κB和XIAP的阳性表达.结果 与对照组相比较,20、40、80 μmol/L百里醌均可显著抑制体外膀胱癌BIU-87细胞生长(81.2%±4.6%,72.5% ±6.5%,58.4%±8.9%比100%,均P<0.05),并明显诱导细胞凋亡(7.6% ±1.6%,11.2%±2.1%,14.3%±2.8%比1.6%±0.5%,均P<0.05);细胞免疫荧光结果显示,百里醌干预后膀胱癌细胞核中NF-κB的表达明显被抑制;百里醌可显著下调BIU-87细胞中NF-κB和XIAP的表达,但对survivin的表达无明显影响.百里醌可显著抑制裸鼠膀胱癌皮下移植瘤生长[(0.41 ±0.12)比(0.89 ±0.23)g,P<0.05],同时明显降低皮下移植瘤组织中Ki-67、NF-κB和XIAP的阳性表达.结论 百里醌可显著抑制体内外膀胱癌生长,该作用可能通过抑制NF-κB及其调控蛋白XIAP的表达而实现.
Objective To explore the effects and mechanism of thymoquinone in the growth inhibition of bladder cancer both in vitro and in vivo.Methods After the treatment of thymoquinone,the cellular proliferation of human bladder cancer cell line BIU-87 was detected by the method of methyl thiazolyl tetrazolium (MTT).Flow cytometry (FCM) was used to determine the cellular apoptosis.And the location of nuclear factor (NF)-κB was identified by the method of immunofluorescent histochemistry. Western blotting was employed to detect the cellular expressions of NF-κB,survivin and XIAP.BIU-87 cells were injected subcutaneously into nude mice to establish a xenograft model.After 2 weeks of implantation,the mice were randomized into 2 groups ( n =8):(a) vehicle alone (control),(b) thymoquinone ( 5 mg/kg daily by intragastric intubation).All treatments lasted for 2 weeks.At Week 7 post-implantation,the mice were sacrificed and their tumor weights and inhibition rates evaluated. Immunohistochemistry was used to detect the positive expressions of Ki-67,NF-κB and XIAP in tumors.Results The proliferation of bladder cancer cells was inhibited significantly by thymoquinone at 20,40,80 μmol/L(81.2%±4.6%,72.5% ± 6.5%,58.4% ± 8.9% vs 100%,all P < 0.05).Apoptosis rate induced by thymoquinone was more significant than that of the control (7.6% ± 1.6%,11.2% ± 2.1%,14.3% ± 2.8% vs 1.6% ± 0.5%,all P < 0.05).Immunofluorescent histochemistry showed that thymoquinone could significantly lower the nuclear expression of NF-κB.The expressions of NF-κB and XIAP were down-regulated in BIU-87 cells after the treatment of thymoquinone.But thymoquinone had no effect on the expression of survivin.The final tumor weight showed significant decrease in the test group versus the control group( (0.41 ± 0.12) vs (0.89 ± 0.23)g,P < 0.05).Furthermore,the positive expressions of Ki-67,NF-κB and XIAP decreased in tumors after the administration of thymoquinone.Conclusion Thymoquinone exerts anti-tumor effects on bladder cancer both in vitro and in vivo through the down-regulations of NF-κB and its regulated molecules such as XIAP.